A practical guide for Canadian LPs: leasing options for extraction gear, eligibility, docs, underwriting, CRA excise “gotchas,” and approval tips.
If you’re a Canadian licensed producer (LP) or processor building extraction capacity (ethanol, CO₂, hydrocarbon, distillation, chromatography), the fastest way to get funded—without starving the business—is usually a leasing-first structure that:
The “best” deal is rarely the lowest payment. It’s the deal that still works when timelines slip 60–120 days, yields are lower in the first batches, and working capital gets squeezed by excise, packaging, and inventory turns.
Key point: Cannabis equipment financing is normal equipment finance—plus regulation, compliance costs, and higher due diligence.
This guide is written for:
It’s not an “extraction how-to.” We stay at the financing/compliance level—because that’s what determines whether your project funds.
Key point: Lenders finance what they can clearly identify, value, insure, and repossess.
Extraction projects often include more than a “machine.” You may be budgeting for:
Why lenders push back:
A lot of these costs live in “soft costs” and “site costs.” Some can be financed, but only if the quote is itemized and tied directly to bringing the equipment into service. When everything is bundled into one lump sum (“turnkey build”), lenders can’t underwrite it cleanly.
Your quote should separate:
Key point: Your licensing stage determines what a lender will fund, how they structure it, and what conditions they’ll attach.
For cannabis processing in Canada, Health Canada’s licensing process runs through the Cannabis Tracking and Licensing System (CTLS), including security clearance applications for identified personnel. Health Canada also notes the site evidence package must be submitted within 10 days after submitting the licence application in CTLS. (Canada)
Once licensed, you must operate under regulatory requirements, including Good Production Practices (GPP) under the Cannabis Regulations (Health Canada provides guidance for licence holders on GPP requirements). (Canada)
Most equipment lessors don’t want to “bet the farm” on a facility that isn’t ready to operate. You’ll typically see different deal shapes depending on where you are:
Key point: In cannabis, tax timing can pinch cash even when the business is “profitable on paper.”
CRA’s cannabis taxation guidance explains that when you become a licensed cannabis producer, you must pay federal excise duty when packaged cannabis products are delivered to a purchaser (for example, a provincial distributor/retailer or final consumer), and that cannabis excise stamps are generally required (with limited exceptions). (Canada)
CRA’s stamping regime guidance also notes that the cost of cannabis excise stamps and secure delivery is the responsibility of the cannabis licensee. (Canada)
Excise and stamping costs affect:
Financing implication: A smart equipment lease is often paired with a working-capital plan (not necessarily more debt—sometimes it’s simply keeping cash on hand by not paying 100% upfront for equipment).
Key point: Most LPs succeed with a lease structure that matches commissioning and reduces early cash strain.
FMV leases typically offer:
Best for:
Underwriter lens: FMV works best when the equipment has an active resale market and is easy to remarket (specialized, hard-to-move systems may reduce flexibility and increase pricing).
This structure is “ownership-focused.”
Best for:
Extraction projects often have long lead times:
A progress-funding structure can:
If you already own valuable equipment (processing gear, packaging lines, certain lab assets), sale-leaseback can turn “metal equity” into cash without shutting down operations—useful for:
Caution: sale-leaseback requires clean title, lien clarity, and insurability.
Key point: Cannabis adds regulatory and reputational risk layers, so lenders “need the story” to be clean.
Health Canada’s licensing materials include specific steps around CTLS submission and security clearances; these elements often become lender conditions (proof of status, evidence of compliance readiness). (Canada)
Key point: Pricing and approvals are shaped by (1) likelihood of trouble, (2) exposure if it happens, and (3) recovery.
Even if lenders don’t say it out loud, they’re managing:
What you can do:
Key point: More questions doesn’t mean “no”—it means you must document legitimacy and controls.
FINTRAC has published operational alerts and indicators related to laundering proceeds from illicit cannabis, designed to help reporting entities identify suspicious transactions. (FINTRAC)
How this affects legitimate LPs:
Lenders and financial institutions may apply enhanced due diligence to ensure:
Practical tip: Have a clean, organized compliance package ready (licensing documentation, corporate structure, major counterparties, bank statements, and a simple flow of funds explanation).
Key point: Most delays are avoidable—if you package the deal like an underwriter.
Create a single PDF pack with:
Key point: The wrong structure can “work” on paper and still break the business.
Key point: If the payment only works in your best-case scenario, lenders will price you higher—or you’ll feel it later.
Do this quick test:
Key point: Cannabis deals often come with tighter conditions—plan for it instead of being surprised.
Common lender requirements include:
Contrarian (but fair) take:
In cannabis, you can sometimes get a “yes” faster by accepting reasonable reporting covenants instead of fighting them—because those covenants reduce the lender’s perceived risk and can improve pricing/structure.
Key point: The win wasn’t “cheap money.” It was building a structure that survived compliance and ramp-up.
Company: Canadian processor (federally licensed), expanding into additional extraction capacity
Project: New extraction system + post-processing equipment + commissioning services
Problem: The business had orders and demand, but cash pressure was building due to:
What broke the first attempt:
They presented the vendor quote as a single lump sum and assumed full throughput within 30 days of delivery—an execution risk red flag.
What we changed (leasing-first):
Outcome:
The company preserved liquidity through commissioning, hit stable output later than initially forecast (as expected), and the financing still “fit” without emergency high-cost capital.
If you’re an LP/processor planning extraction expansion and want a financing structure that accounts for licensing/compliance realities, excise cash timing, and commissioning/ramp risk, Mehmi can help you compare FMV vs $1 buyout vs progress funding, package the file the way lenders underwrite it, and avoid the common traps that delay approvals.
Yes—leasing is commonly used for commercial equipment, and licensed operators often use leases to preserve working capital during commissioning and ramp-up.
Yes. Lenders typically want clarity on your CTLS application/licensing stage and may require evidence steps (including site evidence timing and security clearance progress) as conditions. (Canada)
Excise duty timing and stamping costs can squeeze liquidity even when margins look strong. CRA notes producers must pay excise duty when packaged products are delivered, and licensees bear excise stamp costs. (Canada)
Sometimes, but it’s lender-dependent and usually requires clear itemization and direct linkage to equipment commissioning. Many lenders prefer separating “hard equipment” financing from “site/building” work.
Financial institutions have AML obligations and heightened sensitivity to illicit cannabis indicators; FINTRAC has published alerts and indicators related to illicit cannabis laundering. Legitimate operators can reduce friction with clear licensing and clean fund flows. (FINTRAC)
Provide an itemized quote, a realistic ramp plan, proof of licensing/compliance readiness (GPP posture), show liquidity after deposits, and choose a structure (FMV/$1/progress funding) that survives delays. (Canada)
.avif)
.svg){kind=small}